Financial Benefit News
Most Popular Financial Benefit Story
Ambling APIs look homeward
Circumstantial evidence suggests that the U.S. practice of importing active drug ingredients from Asia may be running out of steam. Last year's tainted heparin fiasco may be one reason, and an April Read more...
Latest Headlines
- November 23, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
